- Home
- CMTL vs VERU Comparison
CMTL vs VERU Comparison
Compare CMTL & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMTL
- VERU
- Stock Information
- Founded
- CMTL 1967
- VERU 1971
- Country
- CMTL United States
- VERU United States
- Employees
- CMTL N/A
- VERU N/A
- Industry
- CMTL Radio And Television Broadcasting And Communications Equipment
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- CMTL Technology
- VERU Health Care
- Exchange
- CMTL Nasdaq
- VERU Nasdaq
- Market Cap
- CMTL 64.4M
- VERU 54.6M
- IPO Year
- CMTL N/A
- VERU 1990
- Fundamental
- Price
- CMTL $2.91
- VERU $4.17
- Analyst Decision
- CMTL Strong Buy
- VERU Strong Buy
- Analyst Count
- CMTL 1
- VERU 3
- Target Price
- CMTL $6.00
- VERU $33.33
- AVG Volume (30 Days)
- CMTL 199.1K
- VERU 165.2K
- Earning Date
- CMTL 10-30-2025
- VERU 08-12-2025
- Dividend Yield
- CMTL N/A
- VERU N/A
- EPS Growth
- CMTL N/A
- VERU N/A
- EPS
- CMTL N/A
- VERU N/A
- Revenue
- CMTL $495,352,000.00
- VERU $16,886,419.00
- Revenue This Year
- CMTL N/A
- VERU N/A
- Revenue Next Year
- CMTL N/A
- VERU N/A
- P/E Ratio
- CMTL N/A
- VERU N/A
- Revenue Growth
- CMTL N/A
- VERU 337.24
- 52 Week Low
- CMTL $1.19
- VERU $2.64
- 52 Week High
- CMTL $4.88
- VERU $14.20
- Technical
- Relative Strength Index (RSI)
- CMTL 56.43
- VERU 60.50
- Support Level
- CMTL $2.44
- VERU $3.92
- Resistance Level
- CMTL $2.93
- VERU $4.44
- Average True Range (ATR)
- CMTL 0.20
- VERU 0.29
- MACD
- CMTL 0.03
- VERU -0.02
- Stochastic Oscillator
- CMTL 52.49
- VERU 54.84
About CMTL Comtech Telecommunications Corp.
Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.